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Abstract 
Background : To compare effects of hydrocolloid 
dressings with povidone-iodine dressings in 
debrided diabetic foot regarding fast wound healing 
and reducing amputation. 
Methods: In this descriptive study patients with 
diabetic foot were enrolled.  In-group A dressings 
was done with hydrocolloid while in-group B 
dressing was done with povidone –iodine. Wounds 
were assessed for depth ischemia classification. 
Vasculopathy, neuropathy and osteomyelitis were 
assessed. Parenteral antibiotics based on culture 
sensitivity were given. Insulin was used according to 
sliding scale. Split Thickness skin grafting was 
performed for all wounds > 5 cm if the wounds were 
found to be clean .Wounds < 5 cm in diameter were 
allowed to epithelize and heal without Split 
thickness skin graft. The total healing period was 
measured by the number of days from the date of 
initial debridement to the date of the Split thickness 
skin grafting or complete epithelization.  
Results: Mean number of days of healing by 
complete epithelization for group A (n= 70/140) were 
40.87 ± 14 . days and mean number of days of healing 
by complete epithelization for group B patients were 
47.16 ± 17.52 days (p- value < 0.05; significant). 
Conclusion: Hydrocolloid (duoderm) is a more 
effective and safe treatment in promoting wound 
healing in diabetic foot ulcers. 
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Introduction 
     The diabetic foot syndrome encircles other 
pathologies like diabetic neuropathy, vasculopathy, 
Charcot's neuroarthropathy, foot ulceration, 
osteomyelitis and the potentially preventable end 
point amputation. A multidisciplinary approach is 
required to deal with diabetic foot complications. 
Amputation rates increase with increase in ulcer 
grade. The principle of dressings in diabetic foot ulcers 
is that it should absorb exudates produced in the 
wounds and it should be non-adherent. 1   Diabetic foot 
ulceration is a serious and financially expensive 
complication with a significant morbidity rate of 15% 
of diabetic patients during their lifetime. Majority 
(80%) of total amputations are secondary to diabetic 
foot ulcers. 2  Foot ulcers occur in 12 to 25 percent of 
persons with diabetes and precede 84 percent of all 
non-traumatic amputations.3,4  Wound care regimens 
have changed dramatically over the last 35 years as the 
physiology of wound healing has become better 
understood. 5 
     Such wounds need weeks or months of treatment 
and sometimes require major amputation.6 The 
multidisciplinary team is necessary to treat diabetic 
ulcers. It will look at medical managements of ulcers 
including dressings, offloading and the treatment of 
infection, either cellulitis or osteomyelitis. There is role 
of surgery in offloading, and the treatment of 
osteomyelitis as well as the role of vascular surgery. 
The most important aspect of management choice is 
the need to focus on the needs of the person with a 
diabetic foot ulcer rather than simply on the treatment 
of the ulcer in isolation.7 Neuropathy, foot deformity, 
high plantar pressures and a history of amputation are 
significantly associated with the presence of foot 
ulceration.8 
    Diabetic foot ulcers, due to neuropathy can now be 
treated with new medical therapies. Even with these 
advances their care usually includes wound 
debridement, appropriate wound dressings, and "off-
loading" the area of the foot that has ulcerated. Off-
loading refers to methods that protect the ulcer from 
the repetitive trauma of activities of daily living. Off-
loading methods include molded shoes, orthotics, 
crutches, wheelchairs, contact casts, and other devices. 
Off-loading helps protect the wound so that it can 
heal.9  
Patients and Methods 
This descriptive  study was carried out at Surgical unit 
of District Headquarters Teaching Hospital 
Rawalpindi, from February  2008 to August 
2008.Keeping prevalence of diabetic foot at 10%7 using 
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the formula and error at 5% sample size was 
calculated to be 140 patients.70 patients in each group, 
were included . 
 Formula : n=Z2PV 
                      E2         
    Patients with type 1 and type 2 diabetes mellitus, 
repeated debridements (bed sided or under 
anasthesia) for diabetic foot wounds with reformation 
of slough in the immediate postoperative period 
(within 72 hours), depth of class 0,1,2,3 (Table 1) and 
ischemia of class A, were included..Patients with 
ischemia of class B, C and D,peripheral vascular 
disease other than diabetic vasculopathy,chronic 
smokers,clean wounds in the immediate postoperative 
period and diabetic osteomyelitis were excluded 
Table 1: Depth classification for diabetic foot. 28 
Depth 
Classification 
Definition Treatment 
0 At-risk foot, 
no ulceration 
Patient education, 
accommodative footwear, 
regular clinical examination 
1 Superficial 
ulceration, not 
infected 
Offloading with total contact 
cast (TCC), walking brace, 
or special footwear 
2 Deep 
ulceration 
exposing 
tendons or 
joints 
Surgical debridement, 
wound care, offloading, 
culture-specific antibiotics 
3 Extensive 
ulceration or 
abscess 
Debridement or partial 
amputation, offloading, 
culture-specific antibiotics 
Ischemia 
Classification 
  
A Not ischemic  
B Ischemia 
without 
gangrene 
Noninvasive vascular 
testing, vascular 
consultation if symptomatic 
C Partial 
(forefoot) 
gangrene 
Vascular consultation 
D Complete foot 
gangrene 
Major extremity amputation, 
vascular consultation 
      Paients were assigned double blind, randomized 
control trials by lottery method. Patients were divided 
in two groups . At the initial visit a full medical history 
and assessment of the patient's present conditions on 
presentation was recorded. Local drainage lymph 
nodes were examined. Any discharge, slough or smell 
was noted. Concomitant medications and their 
indications for use were also recorded. Diabetic status 
of the patient including duration, type, and 
management was noted with current activity level, 
ambulatory status and history of ulceration or 
amputations.Vascular insufficiency was assessed by 
pulse oxymetre and Doppler ultrasound and ABPI. 
Plain X-rays was done to rule out osteomyelitis. 
   The target wound's greatest length, width, and depth 
were measured at initial visit.  The wounds were 
assessed before and after cleansing or debridement for 
local infection and for wound condition (improving, 
stable, or deteriorating). Wound bed    characteristics, 
the peri wound skin was also assessed. Eligible 
patients were treated with either type of dressing 
Duoderm or Povidone–iodine. In-group A dressings 
was done with Hydrocolloid (duoderm) local 
application while in-group B dressing was done with 
povidone –iodine. The dressing of each patient was 
performed by the same dressing staff and 
measurement of wound size was done with measuring 
tape. The surrounding tissue was carefully dried to 
avoid tissue damage.Wounds were assessed for depth 
ischemia classification system . Par-enteral antibiotics 
based on culture sensitivity were given. Insulin was 
used according to sliding scale. 
     In the group A Duoderm dressing was applied as 
the primary dressing. It was then covered with gauze 
and a bandage and tape as the secondary dressing. In 
group B, povidone –iodine   was applied as the 
primary dressing over the wound and covered with 
gauze and a bandage and tape as the secondary 
dressing. Duoderm was applied for 5-7 days and 
changed early if wound had high exudates. Povidone-
Iodine was applied daily once a day or twice a day 
depending on wound condition.  
     The wounds in both groups were thoroughly  
cleaned with normal saline solution at the time of the 
dressing change.Split thickness skin grafting  was 
performed for all wounds > 5 cm if the wounds were 
to be clean and culture of the surface swab were not 
showing any significant bacterial growth. Wounds < 5 
cm in diameter were allowed to epithelize and heal 
without STSG. At each follow up visit, the investigator 
assessed the condition of the primary dressing and the 
study wound, compliance with dressing use and 
change, the use of foot off-loading, changes in 
medication, the presence or absence of any adverse 
events and the number of dressing changes. Ultimate 
evaluation of diabetic ulcers was made whether 
amputation was done or not. The total healing period 
was measured by the number of days from the date of 
initial debridement to the date of the skin grafting or 
complete epithelization. 
 
Results 
       A total of 140 patients were enrolled in the study 
and randomized to two groups. In-group A 
(n=70/140) dressings was done with Hydrocolloid 
(Duoderm) dressing, while in-group B (n=70/140)  
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dressings was done with povidone –iodine. For group 
A, the mean age of patients was 56.06 ± 8.12 years , 
which included males, 32 patients (45.7%) and 
females, 38 patients (54.3%). Majority (57.1%) 
belonged to low socioeconomic status, while 14.3% 
belonged to high class family . Mean duration of 
Diabetes Mellitus in group A was 12.80 ± 7.35 years. 
According to depth classification mean depth of 
wounds was class 2 and size of wounds after 
debridement was 8.24 ± 2.866 cms. In group A Fifty 
five patients (78.6%) had neuropathy and patients 
without neuropathy were 15 patients (21.4%) . In 
group A 43 %  ended up to amputation(Figure 1) and 
57 % were healed by conservative treatment. Total 
number of days of healing required for complete 
epithelization for group A was 40.87± 14.19 days. 
     Results of patients in group B revealed that the 
mean age of patients was 54.59 ± 8.11years , which 
included males 27 patients (38.6%) and females 43 
patients (61.4%) . Thirty five  patients (50.0%) 
belonged to low socioeconomic status, 28 patients (40 
%) belonged to middle class family and 07 patients (10 
%) belonged to high class family . Mean duration of 
Diabetes Mellitus in group B was 10.97±5.72 
years.According to depth classification mean depth of 
wounds was class 2 and size of wounds after 
debridement was 8.1429 ± 2.4980 cms . In group B Fifty 
one patients (72.9%) had neuropathy and patients 
without neuropathy were 19 patients (27.1%) .Total 
number of days of healing required for complete 
epithelization for group B was 47.16 ± 17.52  days . In 
group B forty  one patients (58.6 %) ended up to 
amputation and 29 patients (41.4 %) were healed by 
conservative treatment Number of days for healing of 
wounds for povidone-iodine and Duoderm were 
compared by using independent sample t-test. p- 
value was less than  0.05 which was significant.  Thus 
duoderm dressing is more effective in wound healing 
and helpful for reduction of amputation rate of distal 
extremities. 
Table 2:Wound healing and rate of amputation 
in duoderm versus povidone -iodine group 
 Group A  ( n=70) Group B   ( n=70) 
Size of wound 8.2429 ±2.866cms 8.1429 ±2.498 cms 
Days of healing 40.87 ±14.19 days 47.16±17.52 days 
Amputation  30 41 
Discussion 
    Incidence of diabetes foot lesion is strongly 
associated with poor glycemic control.10-12 Once 
osteomyelitis is established, in a diabetic, it is hard to 
treat and end result may be some kind of amputation. 
The basic principles of the management include early 
detection of diabetic foot, early control of infection, 
control of diabetes and wound care in the form of 
debridement.11-14   
 
 
Figure 1:Transmetatarsal Amputation of medial toes 
 
     The principles of treatment, in diabetic foot,  are 
generous incision, wound debridement and careful 
gentle excision of necrotic tissue along with 
appropriate antibiotics and proper dressings. Non-
conventional dressings like Hypochlorite (Eusol), 
Tetrachlorodecaoxide (Oxoferin), hydrocolloid 
(duoderm) and calcium alginate. Kaltostat can be used 
for diabetic ulcers. If possible, amputations should be 
avoided by good debridements but once the 
amputation is needed, it should be planned to be 
performed once and through the healthy tissue. 15-17 
     Majority of patients in present study, in both the 
groups, belonged to class 2 depth.  Wagener’s 
classification Class 2 is usually the common 
presentation in most of patients.18  All types of diabetic 
foot ulcers are associated with high morbidity and 
mortality. 19 Early diagnosis of osteomyelitis is critical, 
as prompt antibiotic treatment decreases the rate of 
amputation Plain film radiograph yields valuable 
anatomical information at a lower cost. It could be 
followed by a three-phase, bone scan and additional 
imaging as and when needed 20,21 Consistent follow-up 
with prompt treatment of wounds and management of 
callous formation to prevent further injury can result 
in fewer lower extremity amputations in the diabetic 
population. 22 Different studies revealed better wound 
healing and less amputation in Hydrocolloid group.23-
28 Split-skin grafting is an effective method of 
managing diabetic foot ulcers as, compared with the 
conservative dressings, it reduced healing time and the 
length of hospital stay, while donor-site morbidity is 
minimal. 29 Application of HSE (Human skin 
equivalent) with the surgical principles used in a 
traditional skin graft is successful in producing 
healing. HSE may function as a reservoir of growth 
factors that also stimulate wound contraction and 
epithelialisation.30 In the treatment of split-thickness 
skin graft donor sites, honey-impregnated gauzes 
showed faster epithelization time and a low sense of  
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pain than paraffin gauzes and saline-soaked gauzes.31 
Early operative treatments are  to restore anatomical 
alignment and improve function of diabetic patients 
with stage-I Charcot arthropathy. 32                
     Wound measurement is an important 
component of successful wound management. 
Although more complex methods of wound 
measurement exist (planimetry, digitizing techniques, 
and stereophotogrammetry) current practice focuses 
on wound measurement using simple ruler-based 
methods or by wound tracing. Ruler-based schemes 
tended to be less reliable in wounds >5 cm2  33 
     The holistic care of diabetic foot ulcer patients 
requires a multidisciplinary team approach. Apart 
from blood sugar control, treatment of ulcer involves 
debridement; offloading, appropriate dressings like 
hydrogels, foams, calcium alginates, absorbent 
polymers, growth factors and skin replacements can be 
used. Use of adjunctive treatments like growth factors, 
skin replacement dressings and vacuum assisted 
closure will accelerate healing in selected cases.  34 
Conclusion 
1.Early detection of diabetic foot, control of infection, 
control of diabetes and wound care is important.  
2. Hydrocolloid is a more effective and safe treatment 
in  promoting wound healing in diabetic foot ulcers.  
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